Document is current
Any future updates will be listed below
-
Authors
Palmisano, Biagio
Berry, Camryn
Boyce, Alison
Charles, Julia F.
Collins, Michael T.
Corsi, Alessandro
Fierro, Fernando A.
Heegaard, Anne-Marie
van der Heijden, Hanne
Hoffman, Charles S.
Hopkins, Chelsea
Upadhyay, Jaymin
Wehn, Paul M.
Wentworth, Kelly L.
Yang, Yingzi
Zhao, Xuefeng
Hsiao, Edward C.
Riminucci, Mara
- License Information
-
More Information
Article History
Received: 10 January 2025
Accepted: 4 July 2025
First Online: 8 August 2025
Declarations
:
: Not applicable.
: Not applicable.
: JFC has received grant support from Novartis and honoraria from Abbvie, Alexion, Ultragenyx, and Kyowa Kirin. ECH serves in an unpaid capacity on the Medical Registry Advisory Board of the International Fibrodysplasia Ossificans Progressiva Association (FOP); the Fibrous Dysplasia Foundation Medical Advisory Board and Scientific Advisory Board; and the International Clinical Council on FOP. ECH receives clinical trials support through his institution from Clementia Pharmaceuticals, an Ipsen Company; Ipsen Pharmaceuticals; Ascendis Bio, and ashibio.
